Key points from article :
The Rejuvenome project at the Astera Institute aims to fill the gap in research aimed at slowing/reversing mechanisms of aging.
Aging is caused by distinct processes, different forms of cell and tissue damage.
Any one therapy can address only one of these processes, leaving the rest of aging to progress unaffected.
The research and development communities are failing us in their neglect of this point.
Very little work in academia or industry assesses the outcome of combined treatments.
Philanthropic funding must step in to conduct this sort of research, and that is what the Astera Institute principals intend.
Rejuvenome plans to run large, robust mouse studies in aged mice.
Will test combinations of interventions designed to target multiple aspects of aging simultaneously.
Some studies are planned to combine interventions known to or suspected to extend life in mice, to determine synergies.
Expected to launch in earnest, once the mouse study population is old enough, in 2022.
